Skip to content

Opening book details…

Can I read Loss of miR-637 promotes cancer cell stemness via WASH/IL-8 pathway and serves as a novel prognostic marker in esophageal squamous cell carcinoma on EtoBox?

Loss of miR-637 promotes cancer cell stemness via WASH/IL-8 pathway and serves as a novel prognostic marker in esophageal squamous cell carcinoma by Mengxing Guo; Jingyao Lian; Yaqing Liu; Bo Dong; Qianyi He; Qitai Zhao; Hongyan Zhang; Yu Qi; Yi Zhang; Lan Huang is a Medicine article available to read on EtoBox.

What is Loss of miR-637 promotes cancer cell stemness via WASH/IL-8 pathway and serves as a novel prognostic marker in esophageal squamous cell carcinoma about?

## Abstract ## Background Esophageal carcinoma is the highly lethal cancer in the world, predominantly in some areas of East Asia. We previously reported that overexpression of cytoskeleton regulator Wiskott-Aldrich syndrome protein and SCAR Homolog (WASH) associates with poor prognosis of patients with esophageal squamous cell carcinoma (ESCC). However, the molecular mechanism and clinical significance involved in WASH overexpression have not been fully elucidated. ## Methods Bioinformatics analysis and luciferase reporter assay were used to predict and validate miR-637 as a regulator of WASH in ESCC cell lines. qRT-PCR, Western blotting and ELISA assays were performed to examine RNA expression and protein levels, respectively. Next, the biological functions of miR-637 were explored by tumor sphere formation assay in vitro and nude mouse tumor xenograft in vivo. Finally, we evaluated the association of miR-637 levels with clinical features in ESCC patients. ## Results We identified miR-637 as a WASH-targeting miRNA. miR-637 mimic strongly attenuated the downstream IL-8 production and tumor sphere formation in esophageal cancer cells, whereas miR-637 inhibitor displayed an opposite

Who reads Loss of miR-637 promotes cancer cell stemness via WASH/IL-8 pathway and serves as a novel prognostic marker in esophageal squamous cell carcinoma?

It is typically read by researchers, students, and practitioners in Medicine.

Author
Mengxing Guo; Jingyao Lian; Yaqing Liu; Bo Dong; Qianyi He; Qitai Zhao; Hongyan Zhang; Yu Qi; Yi Zhang; Lan Huang
Publisher
Springer Science and Business Media LLC
Published
2022
Language
EN
Field
Medicine (Life Sciences)

More by Mengxing Guo; Jingyao Lian; Yaqing Liu; Bo Dong; Qianyi He; Qitai Zhao; Hongyan Zhang; Yu Qi; Yi Zhang; Lan Huang

Browse all works by Mengxing Guo; Jingyao Lian; Yaqing Liu; Bo Dong; Qianyi He; Qitai Zhao; Hongyan Zhang; Yu Qi; Yi Zhang; Lan Huang